Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.1M Buy
+357,400
New +$38.4M 0.02% 975
2024
Q1
Sell
-10,300
Closed -$758K 6501
2023
Q4
$758K Buy
10,300
+300
+3% +$18.6K ﹤0.01% 4364
2023
Q3
$460K Buy
+10,000
New +$444K ﹤0.01% 4714

Other funds holding NUVL

Israel Englander's NUVL Position: Q2 2026 in Review

Israel Englander increased its Nuvalent (NUVL) stake by 2,138% in Q2 2026, buying an estimated $41.5M and bringing the position to 404,192 shares worth $49.9M. The position accounts for 0.02% of the portfolio, ranked #892.

Israel Englander first reported a position in NUVL in Q2 2022 and has held it in 13 quarters since. 287 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Israel Englander held 404,192 shares of Nuvalent worth $49.9M as of Q2 2026.
  • Israel Englander bought 386,135 Nuvalent shares in Q2 2026, an estimated $41.5M.
  • Nuvalent made up 0.02% of Israel Englander's portfolio in Q2 2026, its #892 holding.
  • Israel Englander first reported a position in Nuvalent in Q2 2022 and has held it in 13 quarters since.
  • 287 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.